Anthony Amoroso, MD
Associate Director, Division of Clinical Care & Research
Associate Chief, Division of Infectious Diseases, Department of Medicine
Institute of Human Virology at the University of Maryland School of Medicine
What are you and your institution currently working on regarding COVID-19?
Currently, my time has been dedicated to direct care and treatment of hospitalized patients, with a focus on immunocompromised patients with COVID-19 infection.
Please elaborate more on your COVID-19 Clinical Care:
My research experience started with climate factors, particularly temperature and humidity as related to transmissibility of COVID-19. Over time, research has broadened, from environmental detection to immune response to mRNA vaccines in immunocompromised patients. However, given the gravity of the medical situation, more of my focus has been on clinical care and developing treatment guidelines for other clinicians.
I am an Associate Professor of Medicine at the Institute of Human Virology at the University of Maryland.
I am highly involved in clinical care and outcomes research both domestically as well as internationally in both HIV and infections associated with immunocompromised patients, particularly those with solid organ transplantations.
My particular research interests center on improving viral suppression rate of first-line antiretroviral therapy in difficult to treat populations. I have focused on both therapeutic strategies, including augmented therapies for HIV as well as HIV clinical care delivery as it pertains to improving adherence and suppression in underprivileged populations.
I have also dedicated my career in HIV and infectious disease education establishing and directing the major outpatient-training program for the UMSOM ID division as the Section Chief for the Baltimore VA Infectious Diseases Division. My international experience is extensive through PEPFAR grants starting in 2004, developing models of sustainable HIV care delivery in both rural and urban Guyana, Haiti, Kenya, Nigeria, Rwanda, Tanzania, and Uganda in the highly successful AIDS Relief Program.
In addition, I have a strong interest in infectious diseases associated with solid organ transplantation, with a particular focus on HIV and transplantation and viral infections of this population. I have dedicated time to further expanding the expertise in transplant infectious disease at the UMMC. Currently, we are working on a collaborative HOPE protocol for HIV organ donation.
About IHV Clinical Care Division
The IHV’s Division of Clinical Care and Research physicians and scientists are world-renowned for their expertise in infectious diseases such as:
- Hepatitis B and C
- Cancers associated with viruses
- Other general infectious diseases, including tuberculosis and Lyme disease
Each member of the Division is committed to providing patients with the most advanced medical care available through our expansive Clinical Care program.
The Division’s clinician researchers capitalize on IHV’s foundation to combine the disciplines of basic science, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics. Our clinical research focuses in the areas of Translational Research, Implementation Science, as well as Special Research programs that includes an in-house Clinical Trials Unit. The Division’s faculty answer pressing clinical research questions informed by their patient care experiences and then implement their findings into practice.